The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Vitamin Shoppe Inc

NYSE: VSI
Last

(U.S.) $29.21

Today's change-0.16 -0.54%
Updated February 9 4:02 PM EST. Delayed by at least 15 minutes.
 

Vitamin Shoppe Inc

NYSE: VSI
Last

(U.S.) $29.21

Today's change-0.16 -0.54%
Updated February 9 4:02 PM EST. Delayed by at least 15 minutes.

Vitamin Shoppe Inc down (U.S.)$0.16

Vitamin Shoppe Inc closed lower Tuesday, dropping (U.S.)$0.16 or 0.54% to (U.S.)$29.21. Over the last five days, shares have lost 2.92% and are down 10.67% for the last year to date. This security has underperformed the S&P 500 by 21.36% during the last year.

Key company metrics

  • Open(U.S.) $29.04
  • Previous close(U.S.) $29.37
  • High(U.S.) $29.63
  • Low(U.S.) $28.81
  • Bid / Ask(U.S.) $24.22 / (U.S.) $34.20
  • YTD % change-10.67%
  • Volume331,345
  • Average volume (10-day)301,872
  • Average volume (1-month)428,435
  • Average volume (3-month)448,322
  • 52-week range(U.S.) $26.25 to (U.S.) $44.83
  • Beta0.51
  • Trailing P/E14.76×
  • P/E 1 year forward14.01×
  • Forward PEG2.37×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $1.98
Updated February 9 4:02 PM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+4.64%

Based on its net profit margin of 4.64%, Vitamin Shoppe Inc is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX2.02%Sector:Cyclical Consumer Goods & ServicesIndustry:Retail - Specialty
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2015Q2/2015Q1/2015Q4/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 26, 201509/26/2015Jun 27, 201506/27/2015Mar 28, 201503/28/2015Dec 27, 201412/27/2014
Revenue314322337290
Total other revenue--------
Total revenue314322337290
Gross profit10510811595
Total cost of revenue209214222195
Total operating expense291299306270
Selling / general / administrative81838477
Research & development--------
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--20-2
Other operating expenses, total--------
Operating income23243120
Interest income (expense), net non-operating0000
Gain (loss) on sale of assets--------
Other--------
Income before tax23233120
Income after tax14141912
Income tax, total99128
Net income14141912
Total adjustments to net income--------
Net income before extra. items14141912
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items14141912
Inc. avail. to common incl. extra. items14141912
Diluted net income14141912
Dilution adjustment----0--
Diluted weighted average shares29293030
Diluted EPS excluding extraordinary itemsvalue per share0.480.480.630.38
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share0.480.520.630.35